Skip to main content

Volume 3 Supplement 2

30th Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2015)

Promoting NK cell trafficking to improve therapeutic effect of NK cell therapy on osteosarcoma

Background

Despite the ability of NK cells to kill cancer cells, NK cell–based immunotherapy has resulted in limited clinical benefit. This is largely due to the poor capacity of adoptively transferred NK cells to home to tumors. We have shown that NK cells are able to kill osteosarcoma (OS) cells in vitro in a dose-dependent manner, indicating that recruiting more NK cells to OS lung metastasis in vivo may help to achieve greater therapeutic benefit. NK cell trafficking is mediated by specific chemokine receptors expressed on NK cells, but the specific receptors necessary for NK cell migration to solid tumors including OS are ill-defined.

Methods

In this study, we demonstrate that the specific chemokine receptor, CXCR2, enhances the migration and infiltration of adoptively transferred NK cells to OS lung metastases in mice.

Results

NK cells have low level expression of CXCR2 and less than 10% of NK cells isolated from human peripheral blood mononuclear cells are CXCR2+. However, selection for an enriched CXCR2+ NK cell population before NK cell transfer to mice bearing OS lung metastases demonstrated that CXCR2+ NK cells have increased tumor infiltration compared to control NK cells. Additionally, over-expression of CXCR2 on NK-92 (NK-92-CXCR2) cells promotes their migration to OS cell conditioned medium in vitro, and enhances their infiltration to lung metastases in vivo. Further, adoptive transfer of NK-92-CXCR2 resulted in improved therapeutic effect on established OS lung metastases.

Conclusions

Given our demonstration of the critical role of CXCR2 in NK cell migration to tumors, our ongoing work aims to develop a strategy to promote NK cell trafficking to OS lung metastases by inducing the expression of CXCR2 on primary human NK cells.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Gangxiong Huang.

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yang, Y., Gordon, N., Kleinerman, E.S. et al. Promoting NK cell trafficking to improve therapeutic effect of NK cell therapy on osteosarcoma. j. immunotherapy cancer 3, P24 (2015). https://doi.org/10.1186/2051-1426-3-S2-P24

Download citation

Keywords

  • Osteosarcoma
  • Human Peripheral Blood Mononuclear Cell
  • Kill Cancer Cell
  • Cell Conditioned Medium
  • Poor Capacity